ImmuCell Corporation Variable Lease, Cost
ImmuCell Corporation (ICCC) reported Variable Lease, Cost of $74.19 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-30
- ImmuCell Corporation variable lease, cost for the quarter ending 2025-12-31 was $15.88K, a 0.00% change year-over-year.
- ImmuCell Corporation variable lease, cost for the quarter ending 2025-09-30 was $18.55K, a 13.68% decline year-over-year.
- ImmuCell Corporation variable lease, cost for the quarter ending 2025-06-30 was $23.87K, a 22.84% increase year-over-year.
- ImmuCell Corporation variable lease, cost for the quarter ending 2025-03-31 was $15.88K, a 63.43% increase year-over-year.
- ImmuCell Corporation variable lease, cost for fiscal 2025 was $74.19K, a 11.52% increase from fiscal 2024.
- ImmuCell Corporation variable lease, cost for fiscal 2024 was $66.52K, a 80.90% increase from fiscal 2023.
- ImmuCell Corporation variable lease, cost for fiscal 2023 was $36.77K, a 1.02% increase from fiscal 2022.
- ImmuCell Corporation variable lease, cost for fiscal 2022 was $36.40K, a 12.07% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $15.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $34.43K derived: sum of 2 quarters · filed 2026-03-30 | $58.30K derived: sum of 3 quarters · filed 2026-03-30 | $74.19K 10-K · filed 2026-03-30 |
| 2025-09-30 | $18.55K 10-Q · filed 2025-11-13 | $42.41K derived: sum of 2 quarters · filed 2025-11-13 | $58.30K 10-Q · filed 2025-11-13 | $74.19K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $23.87K 10-Q · filed 2025-08-14 | $39.75K 10-Q · filed 2025-08-14 | $55.64K derived: sum of 3 quarters · filed 2026-03-30 | $77.13K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $15.88K 10-Q · filed 2025-05-14 | $31.77K derived: sum of 2 quarters · filed 2026-03-30 | $53.26K derived: sum of 3 quarters · filed 2026-03-30 | $72.69K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $15.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $37.37K derived: sum of 2 quarters · filed 2026-03-30 | $56.80K derived: sum of 3 quarters · filed 2026-03-30 | $66.52K 10-K · filed 2026-03-30 |
| 2024-09-30 | $21.49K 10-Q · filed 2025-11-13 | $40.92K derived: sum of 2 quarters · filed 2025-11-13 | $50.64K 10-Q · filed 2025-11-13 | $60.36K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $19.43K 10-Q · filed 2025-08-14 | $29.15K 10-Q · filed 2025-08-14 | $38.87K derived: sum of 3 quarters · filed 2025-08-14 | $48.59K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $9.72K 10-Q · filed 2025-05-14 | $19.44K derived: sum of 2 quarters · filed 2025-05-14 | $29.16K derived: sum of 3 quarters · filed 2025-05-14 | $38.88K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $9.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $19.44K derived: sum of 2 quarters · filed 2025-03-28 | $29.16K derived: sum of 3 quarters · filed 2025-03-28 | $36.77K 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.72K 10-Q · filed 2024-11-13 | $19.44K derived: sum of 2 quarters · filed 2024-11-13 | $27.05K 10-Q · filed 2024-11-13 | $32.41K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $9.72K 10-Q · filed 2024-08-13 | $17.33K 10-Q · filed 2024-08-13 | $22.69K derived: sum of 3 quarters · filed 2024-08-13 | $33.04K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $7.61K 10-Q · filed 2024-05-14 | $12.97K derived: sum of 2 quarters · filed 2024-05-14 | $23.32K derived: sum of 3 quarters · filed 2024-05-14 | $33.67K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $5.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $15.70K derived: sum of 2 quarters · filed 2024-04-01 | $26.05K derived: sum of 3 quarters · filed 2024-04-01 | $36.40K 10-K · filed 2024-04-01 |
| 2022-09-30 | $10.35K 10-Q · filed 2023-11-13 | $20.70K derived: sum of 2 quarters · filed 2023-11-13 | $31.05K 10-Q · filed 2023-11-13 | $41.40K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $10.35K 10-Q · filed 2023-08-10 | $20.70K 10-Q · filed 2023-08-10 | $31.05K derived: sum of 3 quarters · filed 2023-08-10 | $41.40K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $10.35K 10-Q · filed 2023-05-11 | $20.70K derived: sum of 2 quarters · filed 2023-05-11 | $31.05K derived: sum of 3 quarters · filed 2023-05-11 | $41.40K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $10.35K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $20.70K derived: sum of 2 quarters · filed 2023-03-29 | $31.05K derived: sum of 3 quarters · filed 2023-03-29 | $41.40K 10-K · filed 2023-03-29 |
| 2021-09-30 | $10.35K 10-Q · filed 2022-11-21 | $20.70K derived: sum of 2 quarters · filed 2022-11-21 | $31.05K 10-Q · filed 2022-11-21 | $41.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $10.35K 10-Q/A · filed 2022-11-21 | $20.70K 10-Q/A · filed 2022-11-21 | $31.05K derived: sum of 3 quarters · filed 2022-11-21 | $41.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $10.35K 10-Q/A · filed 2022-11-21 | $20.70K derived: sum of 2 quarters · filed 2022-11-21 | $31.05K derived: sum of 3 quarters · filed 2022-11-21 | $41.40K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $10.35K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21 | $20.70K derived: sum of 2 quarters · filed 2022-11-21 | $31.05K derived: sum of 3 quarters · filed 2022-11-21 | $36.52K 10-Q/A · filed 2022-11-21 |
| 2020-09-30 | $10.35K 10-Q · filed 2021-11-15 | $20.70K derived: sum of 2 quarters · filed 2021-11-15 | $26.17K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $10.35K 10-Q · filed 2021-08-12 | $15.82K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $5.47K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |